CD68 and cancer: Classically activated macrophages expressing CD68 (M1) are correlated to antigen presentation and inflammatory response, whereas alternatively activated macrophages expressing CD163 (M2) may be involved in cancer growth, angiogenesis, metastasis and therapy resistance [25,26].